Deccan Health Care Ltd.

As of June 30, 2026, Deccan Health Care Ltd. carries a market capitalization of 331.39M, placing it among publicly traded companies globally. Its enterprise value stands at 331.39M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Deccan Health Care Ltd. has 24.75M shares outstanding.

As of June 30, 2026, Deccan Health Care Ltd. trades at a trailing price-to-earnings ratio of 12.81.

As of June 30, 2026, Deccan Health Care Ltd. trades at an EV/EBITDA multiple of 6.32 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.40 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 8.73 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 331.39M versus a market cap of 331.39M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 10.04M in revenue per employee across its workforce of 81.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Deccan Health Care Ltd. recorded 7.79M in income tax expense. That works out to an effective tax rate of 23.45, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 33.20M, leaving 25.42M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Deccan Health Care Ltd.'s stock has declined approximately 14.56% over the past 52 weeks. The 50-day moving average sits at 12.55, while the 200-day moving average is 12.74.

Over the twelve months ended June 30, 2026, Deccan Health Care Ltd. generated 818.34M in revenue and converted that into 25.42M in net income, yielding earnings per share of 1.05. EBITDA reached 52.42M, while operating income came in at 37.97M.

Over the twelve months ended June 30, 2026, Deccan Health Care Ltd. posted a gross margin of 38.80, reflecting its pricing power and cost economics. The operating margin of 4.64 and net profit margin of 3.11 provide insight into operational efficiency.